Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Am J Med Genet A 2008
As hypothesized, while financial barriers were the most common reason for discontinuation at all time points, patients discontinuing due to cost were more likely to do so later in treatment, whereas those discontinuing due to side effects tended to do so earlier
Retatrutide (RETA-40) 107mg Research Peptide Retatrutide (RETA-40) 107mg research peptide is supplied exclusively for laboratory and analytical research purposes
In Phase 3 clinical trials, the starting dose of retatrutide is 2mg once weekly
US$ 22.26
US$ 24.25
US$ 21.76
US$ 29.41
US$ 29.47
US$ 26.15
US$ 26.86
US$ 22.66
US$ 22.92
